| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.2 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.36 | 0.2 |